Enlivex Therapeutics Newsroom

D. Boral Capital Maintains Buy on Enlivex Therapeutics, Maintains $13 Price Target

BenzingaDec 11 22:42

Enlivex Therapeutics Analyst Ratings

BenzingaDec 3 22:37

Enlivex Therapeutics Is Maintained at Buy by D. Boral Capital

Dow JonesNov 15 06:12

Enlivex Therapeutics Price Target Maintained With a $13.00/Share by D. Boral Capital

Dow JonesNov 15 06:12

H.C. Wainwright Maintains Enlivex Therapeutics(ENLV.US) With Buy Rating, Maintains Target Price $6

Futu NewsSep 27 19:31

H.C. Wainwright Maintains Enlivex Therapeutics(ENLV.US) With Buy Rating, Maintains Target Price $6

Futu NewsSep 9 18:31

Enlivex Therapeutics Price Target Announced at $13.00/Share by EF Hutton

Dow JonesAug 27 20:16

EF Hutton Initiates Coverage On Enlivex Therapeutics With Buy Rating, Announces Price Target of $13

BenzingaAug 27 20:08

Enlivex Therapeutics Analyst Ratings

BenzingaJun 11 18:15

HC Wainwright & Co. Maintains Buy on Enlivex Therapeutics, Lowers Price Target to $6

BenzingaJun 11 18:15

Enlivex Therapeutics Analyst Ratings

BenzingaApr 23 18:35

Enlivex Therapeutics Analyst Ratings

BenzingaApr 12 18:45

Enlivex Therapeutics Analyst Ratings

BenzingaSep 25, 2023 18:14

HC Wainwright & Co. Reiterates Buy on Enlivex Therapeutics, Maintains $15 Price Target

BenzingaAug 1, 2023 18:19

Enlivex Therapeutics Analyst Ratings

BenzingaAug 1, 2023 18:18

HC Wainwright & Co. Reiterates Buy on Enlivex Therapeutics, Maintains $15 Price Target

BenzingaApr 24, 2023 18:40

HC Wainwright & Co. Reiterates Buy on Enlivex Therapeutics, Maintains $15 Price Target

BenzingaApr 5, 2023 18:50

Enlivex Therapeutics Analyst Ratings

BenzingaFeb 24, 2023 19:30

HC Wainwright & Co. Reiterates Buy on Enlivex Therapeutics, Maintains $15 Price Target

BenzingaFeb 24, 2023 19:20

H.C. Wainwright Sticks to Its Buy Rating for Enlivex Therapeutics (ENLV)

TipRanksDec 1, 2022 20:05